JP Morgan Private Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $332M | Sell |
2,228,037
-115,354
| -5% | -$16.9M | 0.95% | 16 |
|
|
2023
Q2 | $316M | Buy |
2,343,391
+85,705
| +4% | +$12.6M | 1.64% | 10 |
|
|
2023
Q1 | $360M | Buy |
2,257,686
+43,815
| +2% | +$6.7M | 0.76% | 25 |
|
|
2022
Q4 | $358M | Buy |
2,213,871
+92,549
| +4% | +$14.2M | 0.8% | 22 |
|
|
2022
Q3 | $285M | Sell |
2,121,322
-151,635
| -7% | -$21.8M | 0.74% | 20 |
|
|
2022
Q2 | $348M | Buy |
2,272,957
+120,902
| +6% | +$18.5M | 0.89% | 17 |
|
|
2022
Q1 | $349M | Buy |
2,152,055
+191,159
| +10% | +$27.8M | 0.76% | 21 |
|
|
2021
Q4 | $266M | Buy |
1,960,896
+58,459
| +3% | +$6.91M | 0.57% | 35 |
|
|
2021
Q3 | $205M | Buy |
1,902,437
+98,204
| +5% | +$11.2M | 0.5% | 44 |
|
|
2021
Q2 | $203M | Buy |
1,804,233
+347,242
| +24% | +$39.1M | 0.53% | 40 |
|
|
2021
Q1 | $158M | Sell |
1,456,991
-132,996
| -8% | -$14.2M | 0.51% | 46 |
|
|
2020
Q4 | $170M | Buy |
1,589,987
+263,908
| +20% | +$25.4M | 0.55% | 40 |
|
|
2020
Q3 | $116M | Buy |
1,326,079
+100,848
| +8% | +$9.49M | 0.45% | 58 |
|
|
2020
Q2 | $120M | Buy |
1,225,231
+157,996
| +15% | +$13.9M | 0.55% | 42 |
|
|
2020
Q1 | $81.3M | Buy |
1,067,235
+86,748
| +9% | +$7.39M | 0.46% | 55 |
|
|
2019
Q4 | $86.8M | Buy |
980,487
+99,932
| +11% | +$8.3M | 0.39% | 68 |
|
|
2019
Q3 | $66.7M | Sell |
880,555
-141,785
| -14% | -$9.72M | 0.35% | 74 |
|
|
2019
Q2 | $74.3M | Sell |
1,022,340
-99,310
| -9% | -$7.81M | 0.41% | 62 |
|
|
2019
Q1 | $90.4M | Sell |
1,121,650
-138,920
| -11% | -$11.4M | 0.47% | 55 |
|
|
2018
Q4 | $116M | Sell |
1,260,570
-61,599
| -5% | -$5.42M | 0.71% | 32 |
|
|
2018
Q3 | $125M | Buy |
1,322,169
+23,562
| +2% | +$2.23M | 0.61% | 36 |
|
|
2018
Q2 | $120M | Buy |
1,298,607
+42,478
| +3% | +$4.15M | 0.67% | 28 |
|
|
2018
Q1 | $119M | Buy |
1,256,129
+54,513
| +5% | +$5.99M | 0.8% | 25 |
|
|
2017
Q4 | $116M | Sell |
1,201,616
-25,497
| -2% | -$2.4M | 0.77% | 28 |
|
|
2017
Q3 | $109M | Sell |
1,227,113
-29,969
| -2% | -$2.28M | 0.78% | 24 |
|
|
2017
Q2 | $91.2M | Buy |
1,257,082
+98,062
| +8% | +$6.59M | 0.69% | 36 |
|
|
2017
Q1 | $75.5M | Buy |
1,159,020
+55,495
| +5% | +$3.49M | 0.58% | 45 |
|
|
2016
Q4 | $69.1M | Buy |
1,103,525
+34,613
| +3% | +$2.11M | 0.6% | 46 |
|
|
2016
Q3 | $67.4M | Buy |
1,068,912
+38,749
| +4% | +$2.51M | 0.63% | 45 |
|
|
2016
Q2 | $63.8M | Buy |
1,030,163
+54,941
| +6% | +$3.35M | 0.62% | 43 |
|
|
2016
Q1 | $55.7M | Buy |
975,222
+90,068
| +10% | +$5.02M | 0.53% | 49 |
|
|
2015
Q4 | $52.4M | Buy |
885,154
+121,286
| +16% | +$6.99M | 0.54% | 47 |
|
|
2015
Q3 | $41.6M | Buy |
763,868
+17,707
| +2% | +$1.15M | 0.52% | 55 |
|
|
2015
Q2 | $50.1M | Buy |
746,161
+57,624
| +8% | +$3.76M | 0.58% | 49 |
|
|
2015
Q1 | $40.3M | Buy |
688,537
+91,991
| +15% | +$5.56M | 0.46% | 61 |
|
|
2014
Q4 | $39M | Buy |
596,546
+9,709
| +2% | +$612K | 0.47% | 63 |
|
|
2014
Q3 | $33.9M | Buy |
586,837
+126,185
| +27% | +$7.01M | 0.44% | 61 |
|
|
2014
Q2 | $26M | Buy |
460,652
+10,761
| +2% | +$565K | 0.44% | 66 |
|
|
2014
Q1 | $23.1M | Buy |
449,891
+15,152
| +3% | +$766K | 0.42% | 70 |
|
|
2013
Q4 | $23M | Buy |
434,739
+14,674
| +3% | +$721K | 0.46% | 67 |
|
|
2013
Q3 | $18.8M | Sell |
420,065
-5,119
| -1% | -$227K | 0.43% | 75 |
|
|
2013
Q2 | $17.6M | Buy |
+425,184
| New | +$18.6M | 0.43% | 76 |
|
Other funds holding ABBV
JP Morgan Private Wealth Advisors's ABBV Position: Q3 2023 in Review
JP Morgan Private Wealth Advisors reduced its AbbVie (ABBV) stake by 4.9% in Q3 2023, selling an estimated $16.9M and leaving 2,228,037 shares worth $332M. The position accounts for 0.95% of the portfolio, ranked #16.
JP Morgan Private Wealth Advisors first reported a position in ABBV in Q2 2013 and has held it in 42 quarters since. The position peaked at $360M in Q1 2023. 3,111 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.
- JP Morgan Private Wealth Advisors held 2,228,037 shares of AbbVie worth $332M as of Q3 2023.
- JP Morgan Private Wealth Advisors sold 115,354 AbbVie shares in Q3 2023, an estimated $16.9M.
- AbbVie made up 0.95% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #16 holding.
- JP Morgan Private Wealth Advisors first reported a position in AbbVie in Q2 2013 and has held it in 42 quarters since.
- JP Morgan Private Wealth Advisors's AbbVie position peaked at $360M in Q1 2023.
- 3,111 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.
Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.